ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 652562 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 652562; 2) Community: the network communities that were significantly associated with the response to NSC 652562; 3) Molecule: the relationships between components within communities and NSC 652562; 4) MDR: the compounds that were significantly associated with the NSC 652562.

NSC Compound Enrichment Correlation
NSC 684906 Null 0.0352028253287042 0.01632638
NSC 685285 Null 0.0352028253287042 -0.1348417
NSC 686551 Null 0.0352028253287042 0.24244124
NSC 709358 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol 0.0352028253287042 0.15732105
NSC 715407 Null 0.0352028253287042 0.29474605
NSC 718781 Erlotinib hydrochloride 0.0352028253287042 0.055354171
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.0352028253287042 0.15867997
NSC 720134 Null 0.0352028253287042 -0.41114556
NSC 726217 Combretastatin A4-analogue 0.0352028253287042 0.0037705007
NSC 748147 5-methyl-2-{[(2)-3-phenylprop-2-enoyl]amino}benzamide 0.0352028253287042 0.1178598
Total:81  Current:55    [First] [Prev] [Next] [Last]